Literature DB >> 24789942

Exacerbation frequency and FEV1 decline of COPD: is it geographic?

Terence A R Seemungal1, Jadwiga A Wedzicha.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24789942     DOI： 10.1183/09031936.00046014

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  5 in total

1.  Characterization and Triggers of Dyspnea in Patients with Chronic Obstructive Pulmonary Disease or Chronic Heart Failure: Effects of Weather and Environment.

Authors:  Ayham Daher; Michael Matthes; András Keszei; Vincent Brandenburg; Tobias Müller; Christian Cornelissen; Michael Dreher
Journal:  Lung       Date:  2018-10-10       Impact factor: 2.584

2.  How to Stage Airflow Limitation in Stable Chronic Obstructive Pulmonary Disease Male Patients?

Authors:  Ichraf Anane; Fatma Guezguez; Hend Knaz; Helmi Ben Saad
Journal:  Am J Mens Health       Date:  2020 May-Jun

3.  Assessing the Usefulness of the Prevexair Smartphone Application in the Follow-Up High-Risk Patients with COPD.

Authors:  Juan Luis Rodríguez Hermosa; Antonia Fuster Gomila; Luis Puente Maestu; Carlos Antonio Amado Diago; Francisco Javier Callejas González; Rosa Malo De Molina Ruiz; Manuel E Fuentes Ferrer; Jose Luis Alvarez-Sala; Myriam Calle Rubio
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-01-08

4.  Testing for Vitamin D in High-Risk COPD in Outpatient Clinics in Spain: A Cross-Sectional Analysis of the VITADEPOC Study.

Authors:  Myriam Calle Rubio; José Luis Álvarez-Sala; Gianna Vargas Centanaro; Ana María Humanes Navarro; Juan Luis Rodríguez Hermosa
Journal:  J Clin Med       Date:  2022-03-01       Impact factor: 4.241

5.  Compliance and Utility of a Smartphone App for the Detection of Exacerbations in Patients With Chronic Obstructive Pulmonary Disease: Cohort Study.

Authors:  Juan Luis Rodriguez Hermosa; Antonia Fuster Gomila; Luis Puente Maestu; Carlos Antonio Amado Diago; Francisco Javier Callejas González; Rosa Malo De Molina Ruiz; Manuel E Fuentes Ferrer; Jose Luis Álvarez Sala-Walther; Myriam Calle Rubio
Journal:  JMIR Mhealth Uhealth       Date:  2020-03-19       Impact factor: 4.773
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.